XBIOTECH INC (XBIT) Stock Balance Sheet
NASDAQ:XBIT - Nasdaq - CA98400H1029 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 155.90M | 172.68M | 200.02M | 157.30M | 237.00M | |||
| Marketable Securities | N/A | N/A | 0.00 | 60.20M | N/A | |||
| Receivables | 638.00K | 858.00K | 935.00K | 1.80M | 9.00M | |||
| Other Current Assets | 1.15M | 1.03M | 760.00K | 600.00K | 900.00K | |||
| Total Current Assets | 157.69M | 174.57M | 201.72M | 219.80M | 246.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.18M | 24.53M | 24.90M | 26.30M | 28.30M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 24.18M | 24.53M | 24.90M | 26.30M | 28.30M | |||
| TOTAL ASSETS | 181.86M | 199.09M | 226.62M | 246.10M | 275.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 10.25M | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.30M | 2.63M | 3.50M | 1.60M | 1.40M | |||
| Accounts Payable | 1.10M | 2.22M | 2.52M | 2.40M | 2.10M | |||
| Other Current Liabilities | 7.00K | 0.00 | 83.00K | 100.00K | 0.00 | |||
| Total Current Liabilities | 5.41M | 15.11M | 6.10M | 4.10M | 3.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 100.00K | 900.00K | |||
| Other Non-Current Liabilities | 1.74M | 1.72M | 1.67M | 1.60M | 1.50M | |||
| Total Non-Current Liabilities | 1.74M | 1.72M | 1.67M | 1.60M | 2.30M | |||
| TOTAL LIABILITIES | 7.15M | 16.82M | 7.77M | 5.70M | 5.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -101.72M | -90.84M | -52.31M | -27.70M | 5.20M | |||
| Common Shares | 276.43M | 273.11M | 271.15M | 267.30M | 262.30M | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 800.00K | 2.00M | |||
| Shares Outstanding | 30.49M | 30.49M | 30.44M | 30.40M | 30.40M | |||
| Tangible Book Value per Share | 5.73 | 5.98 | 7.19 | 7.91 | 8.86 | |||
| Total Shareholders' Equity | 174.71M | 182.27M | 218.85M | 240.40M | 269.40M | |||
| TOTAL LIABILITIES AND EQUITY | 181.86M | 199.09M | 226.62M | 246.10M | 275.20M | |||
| Statistics | ||||||||
| Current Ratio | 29.15 | 11.56 | 33.07 | 53.61 | 70.54 | |||
| Return On Assets (ROA) | -21.67% | -19.59% | -10.84% | -13.37% | -6.33% | |||
| Return On Equity (ROE) | -22.56% | -21.40% | -11.22% | -13.69% | -6.46% | |||
All data in USD , ROIC based on taxRate of 0.21